VIRPAX PHARMACEUTICALS INC (VRPX) Stock Analyst Ratings
USA - NASDAQ:VRPX - US9282512063 - Common Stock
0.6695 USD
-0.55 (-45.12%)
0.4498 USD
-0.22 (-32.82%)
ChartMill assigns a Buy % Consensus number of 43% to VRPX. The Buy consensus is the weighted average rating of the current analysts ratings.
VRPX was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about VRPX.
In the previous month the buy percentage consensus was at a similar level.
VRPX was analyzed by 6 analysts. More opinions would make the average more meaningful.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-10-09 | Maxim Group | Downgrade | Buy -> Hold |
| 2024-07-19 | Maxim Group | Upgrade | Hold -> Buy |
| 2024-05-22 | Maxim Group | Downgrade | Buy -> Hold |
| 2022-06-09 | Maxim Group | Initiate | Buy |
VIRPAX PHARMACEUTICALS INC / VRPX FAQ
What is the consensus rating for VIRPAX PHARMACEUTICALS INC (VRPX) stock?
The consensus rating for VIRPAX PHARMACEUTICALS INC (VRPX) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.